GENERALIZED LIPODYSTROPHY
Clinical trials for GENERALIZED LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for GENERALIZED LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for toddlers with rare fat-loss disease: drug targets diabetes and high fats
Disease control Recruiting nowThis study tests a drug called metreleptin in children under 6 years old who have a rare condition called generalized lipodystrophy, where the body loses fat tissue. These children often develop diabetes and very high blood fats. The goal is to see if metreleptin can safely lower…
Matched conditions: GENERALIZED LIPODYSTROPHY
Phase: PHASE3 • Sponsor: Amryt Pharma • Aim: Disease control
Last updated May 26, 2026 08:28 UTC
-
New hope for rare fat disorder: drug trial targets blood sugar and fat levels
Disease control Recruiting nowThis study tests a new drug, mibavademab, in people with generalized lipodystrophy (GLD), a rare condition where the body lacks fat tissue, leading to serious metabolic problems. The goal is to see if the drug can improve blood sugar and fat levels safely. About 28 children and a…
Matched conditions: GENERALIZED LIPODYSTROPHY
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 08:22 UTC